128 results on '"Wulf, Gerburg"'
Search Results
2. Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry
3. RETRACTED ARTICLE: Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
4. Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms
5. Toker Cell Hyperplasia in the Nipple-Areolar Complex of Transmasculine Individuals
6. Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
7. Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature
8. PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
9. A 13C/31P surface coil to visualize metabolism and energetics in the rodent brain at 3 Tesla
10. The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®
11. MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.
12. STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
13. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
14. Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function
15. Testosterone therapy and breast histopathological features in transgender individuals
16. Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
17. Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
18. Sensitive Multiplexed MicroRNA Spatial Profiling and Data Classification Framework Applied to Murine Breast Tumors.
19. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib
20. Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells
21. Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation
22. Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion
23. Deletion of the gene Pip4k2c , a novel phosphatidylinositol kinase, results in hyperactivation of the immune system
24. Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton
25. Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
26. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
27. Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
28. Durable Response to Programmed Death 1-Directed Antibodies in a Hypermutated Triple-Negative Breast Cancer: A Case Report.
29. The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation
30. Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
31. Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1 / 2 , Germline PALB2 , or Homologous Recombination Deficiency Signature.
32. Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors
33. PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells
34. Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT Pathway Activity in Cell Populations
35. Pinning down HER2–ER crosstalk in SMRT regulation
36. Invasive Ductal Carcinoma of the Breast in a Transgender Man: A Case Report.
37. Inhibition of Hematopoiesis by Competitive Binding of Transcription Factor PU.1
38. cDNA Cloning of a Human mRNA Preferentially Expressed in Hematopoietic Cells and with Homology to a GDP-Dissociation Inhibitor for the rho GTP- Binding Proteins
39. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis
40. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1
41. Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors
42. The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®.
43. Targeting carcinogenesis: A role for the prolyl isomerase Pin1?
44. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
45. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
46. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
47. Waldenstromʼs Macroglobulinemia
48. Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA
49. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
50. Role of Pin1 in the Regulation of p53 Stability and p21 Transactivation, and Cell Cycle Checkpoints in Response to DNA Damage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.